Skip to main content
OpenTrials
Completed

NCT Number: NCT01402154

EPISPOT Detection of Circulating Prostate Cells Among Adenocarcinoma Patients

The primary objective of this study is to evaluate the predictive value (in terms of remission) of a new technique for detecting circulating, functional, prostate cells among patients with localized adenocarcinoma of the prostate, and prior to any treatment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Adenocarcinoma of the Prostate

Age range

18 year and older

Sex eligibility

Male

Study type

Observational

Primary location

CHU de Nîmes - Hôpital Universitaire Carémeau, Nîmes, Gard, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The patient must have given his/her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • Histologically proven presence of prostate adenocarcinoma
  • Localized disease on digital rectal examination
  • Cancer without extensions
  • Acceptance of a curative treatment by the patient

Exclusion criteria

  • The patient is participating in another study
  • The patient is in an exclusion period determined by a previous study
  • The patient is under judicial protection, under tutorship or curatorship
  • The patient refuses to sign the consent
  • It is impossible to correctly inform the patient
  • The patient is taking a hormone-modifying treatment
  • Patient taking adrogenic supplements

Treatment and study plan

EPISPOT detection of the number of circulating cells

Biological

EPISPOT detection of the number of circulating, functional, prostate cells per unit blood

CellSearch detection of the number of circulating, functional, prostate cells

Biological

CellSearch detection of the number of circulating, functional, prostate cells per unit blood

Primary outcomes

  1. The difference between AUCs for the EPISPOT and Cellsearch Techniques

    Time frame: 1 day

    The difference between the AUCs (area under the curve) for the EPISPOT and Cellsearch techniques for detecting functional, circulating prostate cells

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nīmes

Other

Registry information

Official study title

The Pre-treatment Detection of Circulating, Functional, Prostate Cells Among Adenocarcinoma Patients: an Evaluation of the EPISPOT Technique

Important dates

Study start
2012
Primary completion
2021
Study completion
2021
First posted
Jul 26, 2011
Registry last updated
Jun 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.